Integer Holdings Corporation
ITGR
Hisse Senetlerindeki Sıralama
#3855
Integer Holdings Corporation functions as a global leader in outsourced medical... Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Hisse Fiyatı
$126.70
Son senkronizasyon: 2026-10-16
Piyasa Değeri
$4.31B
Değişim (1 gün)
-0.02%
Değişim (1 yıl)
20.86%
Ülke
US
Ticaret Integer Holdings Corporation (ITGR)
Kategori
Healthcare
Integer Holdings Corporation (ITGR) için Faaliyet Marjı
October 2026 itibarıyla Faaliyet Marjı TTM: 9.47%
Integer Holdings Corporation şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 9.47%'dir. 2023 yılı sonunda şirketin faaliyet marjı 10.48% idi.
Integer Holdings Corporation için 2000 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
| Yıl | Faaliyet Marjı | Değiştir |
|---|---|---|
| 2026 (TTM) | 9.47% | -21.93% |
| 2024 | 12.13% | 15.74% |
| 2023 | 10.48% | 18.82% |
| 2022 | 8.82% | -20.61% |
| 2021 | 11.11% | -1.16% |
| 2020 | 11.24% | -10.30% |
| 2019 | 12.53% | -2.11% |
| 2018 | 12.80% | 34.17% |
| 2017 | 9.54% | 22.15% |
| 2016 | 7.81% | -29.00% |
| 2015 | 11.00% | 19.05% |
| 2014 | 9.24% | 131.00% |
| 2012 | 4.00% | -63.13% |
| 2011 | 10.85% | -16.09% |
| 2010 | 12.93% | 102.66% |
| 2009 | 6.38% | 1.59% |
| 2007 | 6.28% | -23.88% |
| 2006 | 8.25% | 17.86% |
| 2005 | 7.00% | -47.99% |
| 2004 | 13.46% | -15.56% |
| 2003 | 15.94% | -3.45% |
| 2001 | 16.51% | 12.08% |
| 2000 | 14.73% | 0.00% |
Benzer şirketler veya rakipler için Faaliyet Marjı
| Şirket | Faaliyet Marjı | Faaliyet Marjı Farkı | Ülke |
|---|---|---|---|
| 17.03% | -98.20% |
US
|
|
| 17.86% | -98.11% |
IE
|
|
| 22.03% | -97.67% |
US
|
|
| 21.46% | -97.73% |
US
|
|
| 0.00% | - |
DE
|
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.